ezetimibe has been researched along with s 8932 in 1 studies
Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (s 8932) | Trials (s 8932) | Recent Studies (post-2010) (s 8932) |
---|---|---|---|---|---|
2,484 | 563 | 1,465 | 1,246 | 52 | 1,207 |
Protein | Taxonomy | ezetimibe (IC50) | s 8932 (IC50) |
---|---|---|---|
NS5 | Zika virus | 1.36 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 3.525 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bašić-Jukić, N; Sabljić, Z | 1 |
1 other study(ies) available for ezetimibe and s 8932
Article | Year |
---|---|
Toxic myopathy and liver damage caused by concomitant therapy with remdesivir, atorvastatin, ezetimibe, and tacrolimus in a renal transplant patient with recently treated SARS-CoV-2 induced pneumonia: A case report.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Atorvastatin; COVID-19 Drug Treatment; Ezetimibe; Humans; Kidney Transplantation; Liver; Myotoxicity; Pneumonia; SARS-CoV-2; Tacrolimus | 2022 |